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It is well known that the human aging process is 
associated with a progressive loss of muscular strength. 
Characteristic of this decline in muscle performance is 
the loss of skeletal muscle mass (sarcopenia) that occurs 
even in the healthy elderly. Indeed, humans can lose as 
much as 40% of their muscle mass from age 20 to 60. 
This significant loss of muscle mass and strength has 
important health and social implications as muscle 
weakness can contribute to an increased risk of falls and 
a loss of independence. Therefore, improving our 
understanding of the mechanisms responsible for 
sarcopenia and the age-related loss of muscle strength is 
important.  
 
The report by Romero-Suarez et al. [1] provides 
important new information regarding a potential cellular 
mechanism that may contribute to sarcopenia. These 
investigators used a combination of experimental 
approaches to phenotypically compare wild type old 
mice with mature mice lacking a novel muscle specific 
inositide phosphatase (MIP/MTMR14) that plays an 
important role in muscle calcium homeostasis. 
Interestingly, the mature MIP/MTMR14 knockout mice 
displayed phenotypes that closely resembled the 
muscles of old animals. Indeed, these relatively young 
knockout mice displayed impaired muscle calcium 
homeostasis, depressed muscle contractile force 
production and a loss of muscle mass that is commonly 
observed in senescent animals. Interestingly, the old 
wild type mice also displayed impaired muscle calcium 
homeostasis and decreases in muscle size and 
contractile function. Importantly, these old mice also 
possessed reduced muscle levels of MIP/MTMR14. The 
authors concluded that these findings were consistent 
with the hypothesis that an age-related loss in 
MIP/MTMR14 may be a contributory factor to 
sarcopenia.  
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The findings of Romero-Suarez et al. [1] are exciting 
and set the stage for future experiments to further 
examine the molecular role that MIP/MTMR14 plays in 
the age-related decline in skeletal muscle mass and 
function. Prior studies by Shen, et al. [2] suggest that 
MIP/MTMR14 deficiency elevates PtdIns(3,4)P2 and 
PtdIns(3,5)P2 levels in the sarcoplasmic reticulum.   
These phosphoinositide derivatives appear to promote 
calcium leak, contractile dysfunction, and protein 
catabolism.  It remains to be seen whether PtdIns(3,4)P2 
and PtdIns(3,5)P2 accumulate in the SR of aged 
muscles.  This is an intriguing possibility.  A detailed 
understanding of the cellular function of MIP/MTMR14 
and the molecular events leading to saropenia may lead 
to clinical countermeasures to slow the age-related loss 
of muscular strength. 
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